EverSource Wealth Advisors, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1710537
BIRMINGHAM, AL
Position in PTGX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$63,003
-$33,012 QoQ
Shares Held
514
-43.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#277
of 341 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EverSource Wealth Advisors, LLC holds $15,234,841 across 258 Biotechnology names. PTGX ranks #33 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
110,689 | $6,036,977 | |
| 2 | INCY |
Incyte Corp
|
9,004 | $1,020,689 | |
| 3 | RPRX |
Royalty Pharma plc
|
13,228 | $741,689 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,357 | $674,058 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
912 | $568,663 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
16,556 | $568,200 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,321 | $452,739 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,146 | $324,502 |
All Filings in PTGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,003 | 514 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $96,015 | 911 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $48,819 | 559 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $35,871 | 540 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,489 | 226 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,303 | 89 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $386 | 10 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||